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ABSTRACT
Objective: Heat shock protein 70 (HSP70) decreases Cyt expression c, Bax, and Caspase 3 in apoptosis multiple organ dysfunction syndrome (MODS), 
thus inhibiting death. This study aimed to analyze the efficacy of HSP70 200 µg/KgBB/ip to decrease Cyt c, Bax, and Caspase 3 expression, to reduce 
mortality, and to increase survival rate, in the MOD alveolar lung epithelial of 78-h sepsis model.
Methods: This was a post-test only quasi-experiment conducted at Inter-University Central Laboratory of Gadjah Mada University, Yogyakarta, and 
the Anatomy Pathology Laboratory, Faculty of Medicine, Universitas Sebelas Maret, Surakarta. The study used a type of Balb/c mice, male, aged of 
6–8 weeks, body weight of 25–33 g. Sepsis induction used LIG SIGMA L2880-10MG Lot #025M4040V from Escherichia coli 055:B5 purified by phenol 
extraction. Medication to reduce mortality used HSP70 Lot #L16020515 and then continued with 400× immunohistochemistry (IHC) examination. 
A sample of 30 mice were divided into three groups: (1) Control group without 78 h treatment, (2) lipopolysaccharide (LPS) group with a dose of 
0.25 mg/kgBW/ip 78 h, and (3) HSP70 group with a dose of 200 μg/kgBB/ip after LPS  injection 0.25 mg/kgBW/ip 78 h. The outcome variables 
included expression of Cyt, Bax, Caspase 3, and mortality in mice model with multiple organ dysfunction syndrome. The data were analyzed by 
Kruskal–Wallis and continued by Mann–Whitney U-test.
Results: Administration of HSP70 200 mg/KgBW/ip after LPS 0.25 mg/kgBW/ip significantly decreased Cyt c expression (p=0.014), Bax (p=0.004), 
and Caspase 3 (p=0.015) in 78 h pulmonary alveolar cells, reduced mortality rate, and increased the number of survivors. Expressions of Cyt c, Bax, 
and Caspase 3 of IHC 400× magnification had a near-normal image change.
Conclusion: There is a decrease of Cyt c, Bax, and Caspase 3 expression in the MOD alveolar lung epithelial cells of the 78-h sepsis model mice, a 
decrease of mortality rate, and an increase of survival rate, and the image of IHC is almost normal.
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INTRODUCTION
Sepsis is a serious and complex problem because metabolic changes 
can lead to apoptotic tissue, multiple organ dysfunction syndrome 
(MODS), sepsis shock, and death [1-4]. Apoptosis, the term introduced 
by Kerr in 1972, is the process of programmed cell death occurring in 
multicellular organisms which causes changes in certain morphological 
and biochemical characteristics and cell death [3,5]. Apoptosis consists 
of two main pathways: The extrinsic or receptor death and the intrinsic 
or mitochondrial [6]. There is now an additional pathway involving 
T-cell-mediated cytotoxicity perforin-granzyme [7,8].
Heat shock protein 70 (HSP70) has been shown to have antiapoptotic 
function, but the mechanism is unclear [9,10]. Cytoprotective 
effects of HSP70 and HSP27 are related to their ability to deactivate 
apoptosis [10]. In mitochondrial apoptosis, HSP interacts closely with 
various components both upstream and downstream. In the mechanism 
of HSP70 in upstream apoptosis as well as in the outer mitochondrial 
membrane, the interaction between cardiolipin and Cyt c becomes 
weaker, allowing Cyt c in the intermembrane space to escape into the 
cytosol, as initiation of apoptosis [10]. In cytosol Cyt c allosteric, apaf-
1 is activated to an apoptosome complex for proteolytic maturation of 
caspase 9 and caspase 3. Activation of caspase eventually leads to the 
removal of apoptotic cells [11]. Afterward, caspase 9 cuts and activates 
caspase 3 and 7 and then splits the number of subintracellulars for 
execution of apoptosis [12]. In the upstream, mitochondrial HSP70 
prevents releasing mitochondrial apoptosis-inducing factor (AIF) 
and prevents nuclear translocation of AIF so that apoptosis does not 
occur [9]. Whereas in the downstream apoptosis mechanism, HSP70 
binds apaf-1 and blocks apoptosome and preventing caspase 3 
activation so that apoptosis does not occur [13-14]. In mitochondrial 
apoptosis, HSP70 placement either in upstream or downstream in 
stress-induced apoptosis pathways shows a mechanism to ensure 
preventable death [15]. Further, research is needed on the importance 
of optimal doses of exogenous HSP70 using ip injection, resulting in 
improved balance of homeostasis and rapid and effective treatment, or 
at least, to reduce very high MODS mortality rates [9,13,16].
Kustanova et al. suggested that injecting HSP70 exogenous at a 
dose  of  266  μg/kg  at  10 min  before  and  10 min  after  administering 
lipopolysaccharide (LPS) at 2 mg/kg iv can reduce mortality and modify 
some hemostasis and hemodynamic parameters [17]. Aschkenasy et al. 
suggested that HSP70 doses of 266 μg/kg exogenous in mice increase 
B-cell lymphoma 2 (BCL2) which inhibit apoptosis [18]. Choudhoury 
et al. stated that exogenous HSP70 administration inhibits apoptosis 
through Cyt c complex release prevention pathways, apaf 1, and pro-
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caspase 9 and 3 [11]. Sharma and Masison state that HSP70 can affect 
apoptosis through the interaction of complementary proteins and 
antiapoptotic proteins BCL 2. Increased HSP70 protects cytotoxicity 
cells from apoptotic, radiation, and chemotherapeutic agents. 
HSP70 binds directly to apaf 1 protease and prevents apoptosome 
formation [19]. Results of Mazzei et al. show that HSP70 inhibits 
apoptosis and inflammation, repairs damaged proteins, prevents folded 
protein aggregation, and targets damaged proteins for degradation and 
cytoskeletal stabilization [20].
This study aimed to determine the effect of HSP70 200 mg/KgBW/i.p. post-
LPS 0.25 mg/KgBW/i.p. on the expression of Cyt c, Bax, and Caspase 3 
in 78 h of lung alveolar cells, mortality, and the number of survivors.
METHODS
This study used laboratory experimental research designed post-test 
only group. Maintenance and treatment were carried out at the Pau 
Laboratory of Gadjah Mada University, Yogyakarta, from 1 to April 
21, 2017, and then continued with immunohistochemistry (IHC) 
examination at the Anatomy Pathology Laboratory, the Faculty of 
Medicine, Universitas Sebelas Maret, Surakarta. Subjects were mice of 
Balb/c strain, male, aged 6–8 weeks with a body weight of ±25–30 g. 
The drug used to cause sepsis was LPS dose of LD75 0.25 mg/KgBW 
from SIGMA L2880-10MG Lot #025M4040V LPS from Escherichia 
coli 055:B5. HSP70 Lot #L16020515 drug was used to reduce the 
expression of Cyt c, Bax, and Caspase 3, to reduce mortality, and to 
increase survival rates. Ethical reviews for this study were provided 
by the research ethics committee of Dr. Moewardi Hospital, Surakarta, 
Central Java, Indonesia, number 377/IV/HREC/2017.
A sample of 30 mice was divided into three groups of 10 mice for each.
P0: Normal control with sodium chloride.
P1: The treatment group received 0.25 mg/KgBW/i.p.
P2: The treatment group received HSP70 injection of 200 µg/KgBW/ip 
post-LPS 0.25 mg/KgBW/ip.
The obtained data were statistically analyzed by one-way ANOVA 
test of the SPSS for Windows Release 11.5, and p<0.05 was chosen 
as the minimum level of statistical significance. The one-way ANOVA 
test requirement is a numerical scale and the data distribution is 
normal and homogeneous. If the one-way ANOVA test showed a 
significant difference (p<0.05), the result would be proceeded with 
the LSD post hoc test. If the one-way ANOVA test requirement could 
not be fulfilled, the non-parametric alternative test of Kruskal–
Wallis would be used. If the Kruskal–Wallis test showed significant 
differences (p<0.05), the post hoc test would be continued using the 
Mann–Whitney U-test.
RESULTS
There were a total of 30 mice of Balb/c strain, male, aged 6–8 weeks 
with a body weight of ±25–30 g. In the treatment group that received 
LPS injection of 0.25 mg/KgBW/ip, there was an increase in Cyt c 
expression (p=0.011), Bax (p=0.005), and Caspase 3 (p=0.011) while in 
the treatment group that received HSP70 of 200 μg/KgBW/ip injection 
after LPS 0.25 mg/kgBW/ip, there was a decrease in Cyt c expression 
(p=0.014), Bax (p=0.004), and Caspase 3 (p=0.015) as shown in Table 1.
Whereas, the description of Cyt c, Bax, and Caspase 3 expression in alveolar 
epithelial cells lung of 78-h sepsis can be seen in Diagram 1: (1) KN: Control 
group without treatment but only injected by 1 cc NaCl intraperitoneal, (2) 
treatment group that received 0.25 mg LPS injection/KgBW/ip to make 
sepsis, and (3) HSP70 group of 200 μg/KgBB/ip after LP 0.25 mg/kgBW/
ip on the lung alveolar epithelium of 78-h MODS model sepsis can be seen 
in Diagram 1.
There was a significant increase in Cyt c expression (p=0.011), Bax 
(p=0.005), and Caspase-3 (p=0.011) in 78 h of pulmonary alveolar 
epithelial cells after LPS injection
HSP70 administration significantly decreased Cyt c expression 
(p=0.014), Bax (p=0.004), and Caspase-3 (p=0.015) in 78 h of 
pulmonary alveolar epithelial cells after LPS injection (Fig. 1).
The results of IHC alveolar epithelial of 78-h sepsis at 400× magnification 
in normal control (NC) where no treatment was performed show a basic 
brownish blurry appearance and Cyt c, Bax, and Caspase 3 expression in a 
less bright brown color with a blurry base. In those who receive LPS injection 
0.25 mg/KgBW/i.p, the expression looks brighter, denser and the base looks 
brighter compared to that of NC. In the HSP70 200 ug/KgBW/ip injection, 
the expression appears to be a reduced brownish color and less dense and 
the base is less bright and almost the same as that of NC.
DISCUSSION
LPS injection of 0.25 mg/KgBW/ip was able to make sepsis in mice 
with increased expression of Cyt c, Bax, and Caspase 3. These results 
are almost in line with Guntur study on making sepsis with LPS 
0.1 mg/Kg BW [1]. In contrast, the results of Markwart et al. show 
LPS injection of 9–11 mg/KgBW/ip injected once cause systemic 
inflammatory response syndrome and sepsis [21]. Zhao et al. suggested 
that low dose LPS ip injection of 5 mg/KgBw is used for studies of 
sepsis and organ injury while high doses of 15 mg/KgBW cause 
death [22]. Fodor et al. increased LPS injection of 3.5, 10 mg/KgBW/ip 
at 6 h resulting in a correlation in dose increase with the severity of 
hypoxemia [23].
At  the  injection  of HSP70 200  μg/KgBW/ip,  there was  a  decrease  in 
the expression of Cyt c, Bax, and Caspase 3. However, in the previous 
studies of HSP70, the dose was generally HSP70 266 ug/KgBB/ip to 
Table 1: Results of Chi‑square test using expression of Cyt c, Bax, and Caspase 3 with LPS injection of 0.25 mg/KgBW/ip to make sepsis 
and to those receiving HSP70 injection of 200 μg/KgBW/ip after LP0.25 mg/kgBW/ip at alveolar lung epithelium of 78‑h MODS sepsis 
model
Organ LPS HSP70
Cyt c Bax Caspase 3 Cyt c Bax Caspase3
Epithelial alveolar lung 78 h p=0.011 p=0.005 p=0.011 p=0.014 p=0.004 p=0.015
Pulmonary alveolar epithelium of 78 h=LPS has a significant increase in Cyt c, Bax, and Caspase 3. HSP 70 has a significant decrease in Cyt c, Bax, and Caspase 3. 
LPS: Lipopolysaccharide, HSP70: Heat shock protein 70, MODS: Multiple organ dysfunction syndrome
Diagram 1: Results of Cyt c, Bax, and Caspase 3 expressions in 
alveolar epithelial cells of 78‑h sepsis. Range magnitude: Value 1: 
Range 1–30%, Value 2: Range 31–70%, Value 3: Range 71–100%
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reduce the expression of Cyt c, Bax, and Caspase 3. As Aschkenasy et al. 
suggest, exogenous HSP70 dose of 266 μg/kgBW in mice increases the 
number of BCL 2 which can inhibit apoptosis [18]. In his study, Kumar 
et al. used HSP70 injection tumor models, dosages varied from 1 µg to 
100 µg to improve TNF-α production [24]. As Choudhoury et al. (2011) 
states, exogenous HSP70 administration inhibits apoptosis through 
the prevention of Cyt c complex release pathways, apoptotic protease-
activating factor 1 (apaf 1), pro-Caspase 9 and 3. Other researchers 
mention  HSP70  injection  exogenous  doses  of  266  μg/kg  at  10  min 
before and 10 min after LPS injection of 2 mg/kg iv can reduce mortality 
rates and modify some hemostasis and hemodynamic parameters [11].
CONCLUSION
Low dose LPS of 0.25 mg/KgBW/ip has been able to make sepsis 
while HSP70 200 ug/KgBW/ip injection has been able to reduce the 
expression of Cyt c, Bax, and Caspase 3 thus can be used for apoptosis 
therapy of MODS of 78-h sepsis model.
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Fig. 1: Overview of immunohistochemistry expressions of Cyt C, 
Bax, and Caspase 3 in epithelial alveolar cells lung of 78‑h 400× 
enlargement sepsis. (a) Normal control (NC), Cyt c, Bax, and 
Caspase 3 expressions (red arrow) are shown in brown less bright 
with an opaque base. (b) Administration of lipopolysaccharide 
0.25 mg/kgBW/i.p, the expressions of Cyt c, Bax, and Caspase 
3 (red arrow) shows brighter brown, denser, and brighter 
base. (c) Administration of Heat shock protein 70 200 g/kgBW/ip 
after lipopolysaccharide injection 0.25 mg/kgBW/ip, the 
expression of Cyt c, Bax, and Caspase 3 (red arrow) shows 
brownish and less dense in which the base is less bright and 
almost the same as that of NC. 1 = Lung alveolar epithelial cells, 
2 = Lung cytosol, 3 = Nucleus of lung cells
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